Verano Holdings (VRNO) Long-Term Investments (2021 - 2023)
Verano Holdings' (VRNO) quarterly Long-Term Investments came in at $100000.0 in Q4 2023, down 98.57% year-on-year from $7.0 million in Q4 2022, and little changed on a QoQ basis from $100000.0 in Q3 2023.
Verano Holdings (VRNO) Long-Term Investments (2021 - 2023) Analysis & Trends
Verano Holdings (VRNO) has 3 years of Long-Term Investments data on file, last reported at $100000.0 in Q4 2023.
- On a quarterly basis, Long-Term Investments fell 98.57% year-over-year to $100000.0 in Q4 2023; TTM through Dec 2023 was $100000.0, a 98.57% decrease from a year earlier, with the FY2023 full-year figure at $100000.0, down 98.57% from the prior year.
- Long-Term Investments for Q4 2023 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
- Over the last five years, Long-Term Investments for VRNO reached as high as $7.3 million in Q2 2022 and fell as low as -$1.7 million in Q4 2021.
- Historically, Long-Term Investments has averaged $4.2 million across 3 years, with a median of $6.8 million in 2023.
- Across the five-year window, Long-Term Investments soared 516.54% in 2022 and tumbled 98.58% in 2023, its largest moves.
- Year by year, Long-Term Investments stood at -$1.7 million in 2021, then surged by 516.54% to $7.0 million in 2022, then sank by 98.57% to $100000.0 in 2023.
- Per Business Quant data, the three most recent Long-Term Investments figures were $100000.0 in Q4 2023, $100000.0 in Q3 2023, and $6.7 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 6.72 Mn |
| Mar 31, 2023 | 6.82 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Sep 30, 2022 | 7.04 Mn |
| Jun 30, 2022 | 7.25 Mn |
| Dec 31, 2021 | -1.68 Mn |